Department of Preventive Medicine, School of Public Health, Wuhan University, Wuhan 430071, China.
Department of Toxicology, School of Public Health, Wuhan University, Wuhan 430071, China.
Int J Environ Res Public Health. 2019 Mar 27;16(7):1091. doi: 10.3390/ijerph16071091.
: Monocarboxylate transport protein 1 (MCT1) has been defined as a critical regulator in tumor energy metabolism, but bibliometric analysis of MCT1 research is rare. This study aimed to comprehensively analyze the global scientific output of MCT1 research and explore the hotspots and frontiers from the past decade. : Publications and their literature information from 2008 to 2018 were retrieved from the Web of Science Core Collection database. We used Microsoft Excel 2016 to detect the trend of annual numbers of publications, and used Citespace V software as the bibliometric method to analyze the research areas, countries, institutions, authors, journals, research hotspots, and research frontiers. : A total of 851 publications were identified with an increasing trend. Relevant literature mainly focused on the field of oncology. The most prolific country and institution were the USA and University of Minho, respectively. Baltazar was the most productive author while Halestrap had the highest co-citations. The hottest topics in MCT1 were hypoxia, gene expression, and CD147 over the last decade. The three research frontier topics were proliferation, tumor cell, and resistance. The special role of MCT1 in human tumor cells has become the focus for scholars recently. : The development prospects of MCT1 research could be expected and researchers should pay attention to the clinical significance of MCT1 inhibitors as anti-cancer or immunosuppressive drugs and the possibility of drug-resistance formation.
单羧酸转运蛋白 1(MCT1)已被定义为肿瘤能量代谢的关键调节因子,但对 MCT1 研究的文献计量分析却很少见。本研究旨在全面分析 MCT1 研究的全球科学产出,并从过去十年中探索研究的热点和前沿。
从 2008 年至 2018 年,从 Web of Science Core Collection 数据库中检索了出版物及其文献信息。我们使用 Microsoft Excel 2016 来检测出版物年度数量的趋势,并使用 Citespace V 软件作为文献计量方法来分析研究领域、国家、机构、作者、期刊、研究热点和研究前沿。
共确定了 851 篇出版物,呈上升趋势。相关文献主要集中在肿瘤学领域。最有成果的国家和机构分别是美国和米尼奥大学。Baltazar 是最有成果的作者,而 Halestrap 拥有最高的共引率。过去十年中,MCT1 最热门的话题是缺氧、基因表达和 CD147。MCT1 研究的三个前沿主题是增殖、肿瘤细胞和耐药性。MCT1 在人类肿瘤细胞中的特殊作用最近成为学者们关注的焦点。
可以预期 MCT1 研究的发展前景,研究人员应该关注 MCT1 抑制剂作为抗癌或免疫抑制药物的临床意义以及耐药性形成的可能性。